These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38841171)

  • 21. Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma.
    Nath LR; Swetha M; Vijayakurup V; Thangarasu AK; Haritha NH; Shabna A; Aiswarya SU; Rayginia TP; Keerthana CK; Kalimuthu K; Sundaram S; Lankalapalli RS; Pillai S; Towner R; Isakov N; Anto RJ
    Front Oncol; 2022; 12():991401. PubMed ID: 36091117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum: Advanced lung cancer inflammation index predicts survival outcomes of hepatocellular carcinoma patients receiving immunotherapy.
    Li Q; Ma F; Wang JF
    Front Oncol; 2024; 14():1431058. PubMed ID: 38915365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum: Real-World Lenvatinib
    Kuo YH; Lu SN; Chen YY; Kee KM; Yen YH; Hung CH; Hu TH; Chen CH; Wang JH
    Front Oncol; 2021; 11():823960. PubMed ID: 34970502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corrigendum: Comparison of clinical outcomes between cone beam CT-guided thermal ablation and helical tomotherapy in pulmonary metastases from hepatocellular carcinoma.
    Wang F; Fan S; Shi Q; Zhao D; Sun H; Sothea Y; Wu M; Song H; Chen Y; Cheng J; Zeng Z; Yan Z; He J; Liu L
    Front Oncol; 2022; 12():1038584. PubMed ID: 36276122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum: Accelerating Decreases in the Incidences of Hepatocellular Carcinoma at a Younger Age in Shanghai Are Associated With Hepatitis B Virus Vaccination.
    Yu S; Zhu Q; Zheng Y; Wu C; Ren H; Liu X; Liu Z; Li Y; Pan Q; Zheng YJ
    Front Oncol; 2022; 12():950499. PubMed ID: 36203441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum: Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
    Liu JN; Li JJ; Yan S; Zhang GN; Yi PS
    Front Oncol; 2023; 13():1233247. PubMed ID: 37427117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corrigendum: Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma
    Li LM; Chen C; Ran RX; Huang JT; Sun HL; Zeng C; Zhang Z; Zhang W; Liu SM
    Front Oncol; 2021; 11():746958. PubMed ID: 34557419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corrigendum: Ribosomal protein L23 drives the metastasis of hepatocellular carcinoma
    Yang M; Zhou Y; Deng H; Zhou H; Cheng S; Zhang D; He X; Mai L; Chen Y; Chen J
    Front Oncol; 2024; 14():1373034. PubMed ID: 38525425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma.
    Kupczyk PA; Kurt D; Endler C; Luetkens JA; Kukuk GM; Fronhoffs F; Fischer HP; Attenberger UI; Pieper CC
    Eur Radiol; 2023 Dec; 33(12):8974-8985. PubMed ID: 37368108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrigendum: Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.
    Han C; Chen J; Huang J; Zhu R; Zeng J; Yu H; He Z
    Front Oncol; 2023; 13():1162375. PubMed ID: 36969048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis
    Wen J; Aili A; Yan YX; Lai Y; Niu S; He S; Zhang X; Zhang G; Li J
    Front Oncol; 2022; 12():1038279. PubMed ID: 36387066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erratum: Extracellular volume fraction using contrast-enhanced CT is useful in differentiating intrahepatic cholangiocellular carcinoma from hepatocellular carcinoma.
    Frontiers Production Office
    Front Oncol; 2023; 13():1282057. PubMed ID: 37736549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients.
    Chen P; Song H; Xu W; Guo J; Wang J; Zhou J; Kang X; Jin C; Cai Y; Feng Z; Gao H; Lu F; Li L
    Front Oncol; 2023; 13():1170066. PubMed ID: 37152060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.
    Zeng YZ; Zhang YQ; Chen JY; Zhang LY; Gao WL; Lin XQ; Huang SM; Zhang F; Wei XL
    Front Oncol; 2021; 11():767805. PubMed ID: 34692552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum: Radiomic machine learning and external validation based on 3.0T mpMRI for prediction of intraductal carcinoma of prostate with different proportion.
    Yang L; Li Z; Liang X; Xu J; Cai Y; Huang C; Zhang M; Yao J; Song B
    Front Oncol; 2024; 14():1401121. PubMed ID: 38634050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erratum: Can a proposed double branch multimodality-contribution-aware TripNet improve the prediction performance of the microvascular invasion of hepatocellular carcinoma based on small samples?
    Frontiers Production Office
    Front Oncol; 2022; 12():1092191. PubMed ID: 36531019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative prediction of microvascular invasion classification in hepatocellular carcinoma based on clinical features and MRI parameters.
    Li MG; Zhang YN; Hu YY; Li L; Lyu HL
    Oncol Lett; 2024 Jul; 28(1):310. PubMed ID: 38784602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
    Min JH; Lee MW; Park HS; Lee DH; Park HJ; Lim S; Choi SY; Lee J; Lee JE; Ha SY; Cha DI; Carriere KC; Ahn JH
    Radiology; 2020 Dec; 297(3):573-581. PubMed ID: 32990512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial-Mesenchymal Transition.
    Yang B; Chen Q; Wan C; Sun S; Zhu L; Zhao Z; Zhong W; Wang B
    Front Oncol; 2022; 12():888600. PubMed ID: 35425696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of microvascular invasion of hepatocellular carcinoma: value of volumetric iodine quantification using preoperative dual-energy computed tomography.
    Kim TM; Lee JM; Yoon JH; Joo I; Park SJ; Jeon SK; Schmidt B; Martin S
    Cancer Imaging; 2020 Aug; 20(1):60. PubMed ID: 32811570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.